| Literature DB >> 25012957 |
Sophia S C Chan1, Doris Y P Leung2, Angela Y M Leung3, Cindy Lam4, Ivan Hung5, Daniel Chu6, Chi Kuen Chan7, Janice Johnston8, Shao Haei Liu9, Raymond Liang5, Tai Hing Lam8, Kwok Yung Yuen10.
Abstract
BACKGROUND: The 23-valent pneumococcal polysaccharide vaccine is recommended for elders, especially those with chronic conditions.Entities:
Keywords: Interventions; Older patients; Pneumococcal vaccination; Randomized controlled trial
Mesh:
Substances:
Year: 2014 PMID: 25012957 PMCID: PMC7094619 DOI: 10.1016/j.ijnurstu.2014.06.008
Source DB: PubMed Journal: Int J Nurs Stud ISSN: 0020-7489 Impact factor: 5.837
Fig. 1Topics covered in the multi-component health education intervention for the intervention group.
Fig. 2Flow chart of study participants through the trial.
Baseline characteristics of subjects in the intervention and control groups, n (%) unless otherwise stated.
| Characteristics | Intervention group ( | Control group ( |
|---|---|---|
| Mean (SD) age in years | 74.4 (5.4) | 74.7 (5.8) |
| Male | 519 (41) | 556 (44) |
| Married | 984 (79) | 928 (73) |
| Primary Education or below | 955 (76) | 928 (73) |
| More than 1 chronic disease | 412 (33) | 375 (30) |
| Current smoker | 77 (6) | 59 (5) |
| Current drinker | 90 (7) | 71 (6) |
| Exercise in the past 30 days | 982 (79) | 1027 (81) |
| Perceived good health in the past month | 991 (79) | 1013 (80) |
| Prior vaccination other than PPV | 610 (49) | 550 (43) |
| Awareness of PPV | 266 (21) | 314 (25) |
| Mean (SD) perceived stress (range: 0–4, higher score indicates higher stress) | 1.26 (0.77) | 1.19 (0.78) |
| Mean (SD) self-efficacy in controlling disease (range: 0–4, higher score indicates better control) | 2.50 (0.76) | 2.57 (0.81) |
PPV, pneumococcal polysaccharide vaccine.
11 subjects in the intervention group and 13 subjects in the control group did not complete the scale and were excluded from the analysis.
9 subjects in the intervention group and 8 subjects in the control group did not complete the scale and were excluded from the analysis.
PPVa uptake and reasons for not receiving PPV at 1-week.
| Intervention ( | Control ( | ARR | |
|---|---|---|---|
| Computer-recorded PPV uptake | 716 (57.2) | 609 (48.1) | 1.2 (1.06, 1.37) |
| Awareness of PPV at 3-month, | 803 (64.2) | 734 (58.0) | 0.86 (0.69, 1.07) |
PPV, pneumococcal polysaccharide vaccine.
Relative risk (RR) for Clinical Management System-recorded PPV uptake associated with the intervention adjusted for the effects of clustering, clinic, patient's educational level, whether have vaccination in the past 12 months and whether was aware of PPV at baseline.